Navigation Links
CV Therapeutics Reports 2007 Third Quarter Financial Results
Date:11/6/2007

s 1,407 - 6,774 -

Total costs and expenses 53,665 76,312 207,910 232,976

Loss from operations (33,902) (64,110) (147,489) (208,860)

Other income (expense), net:

Interest and other income, net 2,847 4,582 10,112 12,100

Interest expense (3,166) (3,166) (9,498) (9,501)

Total other income (expense), net (319) 1,416 614 2,599

Net loss $(34,221) $(62,694) $(146,875) $(206,261)

Basic and diluted net loss

per share $(0.58) $(1.23) $(2.48) $(4.36)

Shares used in computing basic

and diluted net loss per share 59,458 51,067 59,213 47,340

(1) Costs and expenses include non-recurring stock-based compensation expense related to the acceleration of stock options and the voluntary forfeiture of stock appreciation rights as follows:

Cost of sales $- $- $109 $-

Research and development - - 4,606 -

Selling, general and

administrative - - 8,471 -

Total non-recurring

stock-based compensation

charges $- $- $13,186 $-

Reconciliation of GAAP Items

to Non-GAAP Items (2):

Net loss, as reported $(34,221) $(62,694) $(146,875) $(206,261)

Adjustments:

Non-recurring stock-based

compensation charges - - 13,186 -

Restructuring charges 1,407 - 6,774 -

Net loss, non-GAAP $(32,814) $(62,694) $(126,915) $(206,261)

Basic and diluted net loss

per share, as reported $(0.58) $(1.23) $(2.48) $(4.36)

Adjustments
'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Prime Therapeutics Receives TIPPS Certification
2. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
3. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
4. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
5. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
6. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
7. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
8. Prime Therapeutics Announces URAC Accreditation
9. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
10. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
11. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2014)... Demand Response Management Systems is a crucial ... the imbalance between energy supply and demand. With the ... out (due to increasing pressure on the grid) and ... controlling residential appliances and thermostats for load reduction. ... region, and with government mandates and benefits for energy ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 Casinos ... years, despite rising competition from international and online casinos. ... 2.9% over the five years through 2014-15. Greater per ... demanding more gaming services. Rises in discretionary income levels ... more money on non-essential items such as casino gambling ...
(Date:7/12/2014)... 2014 Sean Francis, owner of the Kawartha Lakes ... to his clients. He’s also known for his support of local ... way to combine the two and is excited to announce that ... Boys and Girls Club. , The funds are the result of ... 23rd. Francis sent out emails and asked his clients to put ...
(Date:7/12/2014)... prom shopping reaching its final days, VogueQueen.com, a renowned ... its new and trendy apparels. Recently, the company has ... online shop. Additionally, it is now providing huge discounts ... to the company’s sales manager, the promotion will come ... He says, “Now, worldwide clients can order cheap ...
(Date:7/12/2014)... 12, 2014 Doylestown Hospital recently conducted ... of men’s health questions. Paddock tackles topics including ... why women live longer than men, and testosterone replacement ... Made Simple featured on Doylestown Hospital’s website, Dr. ... at any age. If you notice pain, bulging, or ...
Breaking Medicine News(10 mins):Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 4Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:Kawartha Lakes Fit Body Boot Camp’s Successful Fat Loss Challenge Results in $2,000 to Boys and Girls Club 2Health News:Kawartha Lakes Fit Body Boot Camp’s Successful Fat Loss Challenge Results in $2,000 to Boys and Girls Club 3Health News:VogueQueen.com Updates Its Summer Collection With New And Trendy Evening Dresses 2Health News:Ivyland Medical Center’s Dr. Brad Paddock Offers Tips for Men’s Health 2
... key component of butter flavoring in microwave brands , SATURDAY, ... the buttery flavoring of microwave popcorn has been identified as ... afflicts people who work in the microwave popcorn manufacturing industry, ... issue of the American Journal of Respiratory and Critical ...
... bedtime pay the price down the road, European researchers say , , ... asleep in their morning cereal, check their cell phones -- even ... needed sleep. , A new study found that teens who reported ... doubled their odds of being very tired a year later. Those ...
... and other racial minorities have sleep durations associated with ... that unhealthy sleep patterns among minorities long sleep ... according to a study published in the September 1 ... by Lauren Hale, PhD, assistant professor in the graduate ...
... Work time is the primary lifestyle factor with the ... more hours a person works, the less sleep that he ... September 1 issue of the journal SLEEP. , The study, ... focused on a total of 47,731 respondents to the American ...
... Calif., Aug. 31 DaVita Inc.,(NYSE: DVA ), ... complaint filed,in U.S. District Court for the Central District ... The complaint names as defendants,Amgen, Inc., Fresenius Medical Care ... yet been served on DaVita, is styled as a ...
... KIDS OF KILIMANJARO ANNUAL GALA, Program provides school lunches to over 10,000 students ... ... Calif., Aug. 31 When Mary and,Joseph Mwanisawa agreed to travel over 15,000 ... lunch program, they,thought they were going to America only to tell their story ...
Cached Medicine News:Health News:Scientists ID Likely Culprit in 'Popcorn Lung' 2Health News:Teens' Cell Talk at Night Can Be Tiring 2Health News:Minorities more likely to have sleep durations associated with increased mortality 2Health News:Minorities more likely to have sleep durations associated with increased mortality 3Health News:Work time is the largest influence to the duration of a person's sleep 2Health News:Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach 2Health News:Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach 3
(Date:7/11/2014)... MELBOURNE, Australia , July 11, 2014  Australian ... today announced that it has raised A$19.3 million via ... Europe , the U.S., ... and A$3 million from a share purchase plan (SPP) ... A$16.3 million will be made in two tranches. ...
(Date:7/11/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/tjlw9k/immunoprotein ... "Immunoprotein Diagnostic Testing Market - Forecasts to 2019: ... 6% and is expected to be valued at ... http://photos.prnewswire.com/prnh/20130307/600769 ... been segmented according to immunoprotein types which include ...
(Date:7/11/2014)... 2014 Neurelis, Inc. ("Neurelis") today announced an ... option held by Biotie to purchase Neurelis, clearing the ... (intranasal diazepam) for pediatric and adult epilepsy patients who ... year, Biotie has advanced the development program for NRL-1 ... clinical work required for NDA submission to the FDA.  ...
Breaking Medicine Technology:Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million 2Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3
...  Millennium Laboratories announced today the Clinical Laboratory Responsibility ... responsible and ethical business practices in the medication ... which Millennium adheres and to which the company ... industry to adopt. (Logo: ...
... Inc., a critical care company focused on developing and commercializing ... Center for Devices and Radiological Health ... Administration (FDA) has granted 510(k) clearance for compatibility of its ... INOMAX DS and the INOMAX DSIR have now been validated ...
Cached Medicine Technology:Millennium Laboratories Announces Laboratory Responsibility Pledge 2Millennium Laboratories Announces Laboratory Responsibility Pledge 3FDA Clears Expanded Compatibility for INOMAX® Drug-Delivery Systems 2FDA Clears Expanded Compatibility for INOMAX® Drug-Delivery Systems 3
... Hand-Held Pulse Oximeter provides SpO 2 and ... adult. The device is battery or AC ... visible and audible alarm signals, and an infrared ... rubber boot is also available for added protection. ...
... Hand-Held Pulse Oximeter with built-in Summary ... screening studies in the sleep lab, ... its easy-to-use, 2-key operation, it also ... SpO 2 , pulse rate and ...
... is a cost-effective, stand-alone monitor that delivers ... and pulse strength measurements of patients from ... battery powered unit displays a plethysmographic waveform, ... to 30 hours of on screen trended ...
... Administration (FDA) has granted approval of Alcon's ... patients with and without presbyopia. This innovative ... to give patients a full range of ... greatly increases their independence from glasses after ...
Medicine Products: